GNRH1 and ovarian hyperstimulation syndrome: In Wang et al. (16)study, a head-to-head comparison of letrozole to Cetrorelix(GnRH antagonist) showed no difference in the incidenceof moderate to severe OHSS, hospitalization days, or duration ofthe luteal phase.